- Home
- CADL vs GROY Comparison
CADL vs GROY Comparison
Compare CADL & GROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- GROY
- Stock Information
- Founded
- CADL 1999
- GROY 2020
- Country
- CADL United States
- GROY Canada
- Employees
- CADL N/A
- GROY N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- GROY
- Sector
- CADL Health Care
- GROY
- Exchange
- CADL Nasdaq
- GROY Nasdaq
- Market Cap
- CADL 278.6M
- GROY 322.2M
- IPO Year
- CADL 2021
- GROY 2021
- Fundamental
- Price
- CADL $5.95
- GROY $3.16
- Analyst Decision
- CADL Strong Buy
- GROY Strong Buy
- Analyst Count
- CADL 5
- GROY 4
- Target Price
- CADL $21.40
- GROY $4.58
- AVG Volume (30 Days)
- CADL 627.9K
- GROY 2.3M
- Earning Date
- CADL 08-14-2025
- GROY 08-06-2025
- Dividend Yield
- CADL N/A
- GROY N/A
- EPS Growth
- CADL N/A
- GROY N/A
- EPS
- CADL N/A
- GROY N/A
- Revenue
- CADL N/A
- GROY $12,376,000.00
- Revenue This Year
- CADL N/A
- GROY $84.26
- Revenue Next Year
- CADL N/A
- GROY $50.03
- P/E Ratio
- CADL N/A
- GROY N/A
- Revenue Growth
- CADL N/A
- GROY 90.37
- 52 Week Low
- CADL $3.79
- GROY $1.16
- 52 Week High
- CADL $14.60
- GROY $3.26
- Technical
- Relative Strength Index (RSI)
- CADL 47.68
- GROY 64.88
- Support Level
- CADL $5.45
- GROY $2.89
- Resistance Level
- CADL $6.16
- GROY $3.09
- Average True Range (ATR)
- CADL 0.32
- GROY 0.17
- MACD
- CADL -0.07
- GROY -0.01
- Stochastic Oscillator
- CADL 48.54
- GROY 79.17
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About GROY Gold Royalty Corp.
Gold Royalty Corp is a precious metals-focused royalty and mineral streaming company. The company offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests. The company derives maximum revenue from Canada.